Background
Methods
Patients
COS protocols
Endometrial preparation schemes
Outcomes
Statistical analysis
Results
Baseline characteristics and treatment outcomes of women with or without live birth
Variables | Live birth (N = 2643) | No live birth (N = 253) | P |
---|---|---|---|
Age (years) | 28.0(25–30) | 27.5(25–31) | NS |
Body mass index (kg/m2) | 21.9(20.0–24.2) | 22.0(19.9–24.4) | NS |
Basal follicle-stimulating hormone (IU/L) | 5.97(5.09–7.0) | 6.11(5.01–7.15) | NS |
Basal luteinizing hormone (IU/L) | 5.69(4.25–8.16) | 5.50(4.21–7.60) | NS |
Basal antral follicular count (n) | 18(13–24) | 17(11–24) | 0.031 |
Cause of infertility | NS | ||
Male factor | 26.0% (686/2643) | 25.3% (64/253) | |
Tubal disease | 39.0% (1032/2643) | 41.5% (105/253) | |
PCOS | 13.7% (363/2643) | 9.9% (25/253) | |
Endometriosis | 1.3% (33/2643) | 0.8% (2/2530) | |
Unexplained | 20.0% (529/2643) | 22.5% (57/253) | |
Insemination method | NS | ||
IVF | 69.7% (1838/2643) | 67.6% (171/253) | |
ICSI | 30.3% (798/2643) | 32.4% (82/253) | |
Stimulation protocols | NS | ||
Long-acting GnRH-a long protocol | 35.4% (936/2643) | 33.2% (84/253) | |
Short-acting GnRH-a long protocol | 63.5% (1647/2643) | 65.2% (165/253) | |
Unrecorded | 1.1% (33/2643) | 1.6% (4/253) | |
Gonadotropin dosage (IU) | 1537(1237–1987) | 1650(1331–2250) | 0.002 |
Fertilization rate(%) | 0.69(0.57–0.80) | 0.61(0.46–0.73) | 0.000 |
Peak E2 on HCG day (IU/L) | 7276(4991–9484) | 7084(4448–9103)0 | NS |
No. of oocytes retrieved(n) | 20(16–25) | 18(14–21) | 0.000 |
IVF/ICSI outcome of each oocyte-stratified group in the “freeze-all” strategy analysis
Variables | Group 1 (N = 109) | Group 2 (N = 1553) | Group 3 (N = 987) | Group 4 (N = 211) | Group5 (N = 36) |
---|---|---|---|---|---|
Age (years) | 28(25–31) | 28(26–30) | 28(25–30) | 28(25–30) | 27(25–30) |
BMI (kg/m2) | 20.8(19.3–23.0) bcd | 21.5(19.6–23.9) αβ | 22.0(20.3–24.6) | 22.6(20.8–25.0) | 23.4(20.8–26.6) |
Basal FSH (IU/L) | 6.4(5.24–7.45) bcd | 6.1(5.22–7.14) αβγ | 5.7(4.95–6.76) | 5.6(4.82–6.48) | 5.5(4.63–6.36) |
Basal LH (IU/L) | 5.57(3.98–7.22) | 5.53(4.18–7.78) β | 5.72(4.29–8.49) | 6.43(4.55–9.09) | 6.93(4.70–8.67) |
Peak E2 on HCG day (IU/L) | 6358(3425–8676) bcd | 6966(4754–9122) αβγ | 7778(5314–9732) | 8038(5477–10,929) | 8863(5696–11,939) |
Basal AFC (n) | 14(10–20)bcd | 17(12–22) βγ | 20(14–24) | 22(15–24) | 24(22.5–24) |
Gn dosage (IU) | 1575(1231–1925) | 1537(1237–1950) β | 1575(1275–2062) | 1637(1312–2387) | 1631(1406–2493) |
Fertilization rate (%) | 0.70(0.60–0.88) bcd | 0.71(0.57–0.81) αβ | 0.67(0.55–0.76) | 0.67(0.56–0.75) | 0.62(0.53–0.74) |
CCPR [%(n/N)] | 81.65(89/109) abcd | 92.85(1442/1553) α | 95.74(945/987) | 95.73(202/211) | 97.22(35/36) |
CLBR [%(n/N)] | 72.48(79/109) abcd | 90.28(1402/1553) α | 93.82(926/987) | 95.26(201/211) | 97.22(35/36) |
Multivariate logistic regression analysis of the CLBR for the “freeze-all” strategy
Predictors | aOR (95% CI) | P |
---|---|---|
Age | 1.007(0.963–1.054) | 0.749 |
Body mass index | 1.003(0.955–1.052) | 0.961 |
Basal antral follicular count | 1.004(0.978–1.031) | 0.764 |
Basal follicle-stimulating hormone | 1.029(0.951–1.113) | 0.474 |
Basal luteinizing hormone | 1.016(0.983–1.050) | 0.347 |
Log10 (Gn) dosage | 0.195(0.059–0.640) | 0.007 |
E2 on HCG day | 0.958(0.478–1.920) | 0.903 |
Stimulation protocols | 0.108 | |
Long-acting GnRH-a long protocol | 1 | |
Short-acting GnRH-a long protocol | 0.686(0.473–0.994) | 0.047 |
Unrecorded | 1.306(0.366–4.659) | 0.680 |
Insemination method | ||
IVF | 1 | |
ICSI | 0.808(0.596–1.097) | 0.172 |
Oocyte yield | 0.000 | |
4–10 | 1 | |
11–20 | 3.987(2.411–6.564) | 0.000 |
21–30 | 6.851(3.924–11.960) | 0.000 |
31–40 | 9.579(4.122–22.259) | 0.000 |
≥ 40 | 18.378(2.312–146.101) | 0.006 |
Fertilization rate | 16.877(8.100–35.166) | 0.000 |
Variables | Number of attempt(s) | ||||
---|---|---|---|---|---|
1 (N = 117) | 2 (N = 151) | 3 (N = 77) | 4 (N = 26) | 5 (N = 9) | |
Age (years) | 28(26–30) | 28(26–31) | 29(27–31) | 29(26–31) | 27(24–28) |
Body mass index (kg/m2) | 22.5(20.0–25.4) | 22.3(20.2–25.7) | 22.6(20.3–25.4) | 24.9(21.3–26.8) | 24.0(20.1–26.6) |
No. of oocytes yielded (n) | 6(5–9) ab | 8(6–11) α | 10(8–13) | 13(10–18) | 15(11.5–16) |
No. of embryos used / No. of oocytes yielded (%) | 0.33(0.25–0.50) ab | 0.57(0.40–0.71) α | 0.73(0.55–0.83) | 0.73(0.64–0.88) | 0.92(0.80–0.93) |
No. of embryos left / No. of oocytes yielded (%) | 0.67(0.50–0.75) ab | 0.43(0.29–0.60) α | 0.27(0.17–0.45) | 0.27(0.13–0.26) | 0.08(0.07–0.20) |